Status:
UNKNOWN
Genomics and Metagenomics of Asthma Severity
Lead Sponsor:
Maria Pino-Yanes
Collaborating Sponsors:
University of La Laguna
Ministry of Science and Innovation, Spain
Conditions:
Asthma
Asthma Attack
Eligibility:
All Genders
8-85 years
Brief Summary
The Genomics and Metagenomics of Asthma Severity (GEMAS) study aims to assess the role of genomics, the microbiome, and the interaction between them in the development of asthma exacerbations in Europ...
Detailed Description
Asthma is a chronic inflammatory disease of the airways characterized by reversible airflow obstruction and a bronchial hyperreactivity in response to a variety of stimuli. In most patients, the onset...
Eligibility Criteria
Inclusion
- Male or female aged older or equal than 8 years and younger or equal than 85 years
- Physician diagnosis of asthma according to the Global Initiative for Asthma (GINA) guidelines
- Treated on GINA step 1-5
Exclusion
- One or more grandparents of non-European origin
- Pregnancy
- Coexistence of other chronic pulmonary disorders including cystic fibrosis, chronic obstructive pulmonary disease (emphysema or chronic bronchitis), or congenital disorders of the lungs or airways
- Known family relatedness (first or second degree) with another participant already included in the study
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04501926
Start Date
March 1 2018
End Date
December 31 2023
Last Update
May 17 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
University of La Laguna
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain, 38200
2
Hospital Doctor Jose Molina Orosa
Arrecife, Spain
3
Hospital General de La Palma
Breña Alta, Spain
4
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Spain